Sulfatide imaging identifies tumor cells in colorectal cancer peritoneal metastases
Abstract Even with systemic chemotherapy, cytoreductive surgery (CRS), and hyperthermic intraperitoneal chemotherapy (HIPEC), peritoneal metastases (PM) remain a common site of disease progression for colorectal cancer (CRC) and are frequently associated with a poor prognosis. The mass spectrometry...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2024-06-01
|
| Ráidu: | Cancer & Metabolism |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s40170-024-00345-3 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
